170 related articles for article (PubMed ID: 28206666)
21. Reassessment of lymphocytic atypia in the diagnosis of mycosis fungoides.
Yeh YA; Hudson AR; Prieto VG; Shea CR; Smoller BR
Mod Pathol; 2001 Apr; 14(4):285-8. PubMed ID: 11301344
[TBL] [Abstract][Full Text] [Related]
22. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides.
Kallinich T; Muche JM; Qin S; Sterry W; Audring H; Kroczek RA
J Invest Dermatol; 2003 Nov; 121(5):1045-52. PubMed ID: 14708605
[TBL] [Abstract][Full Text] [Related]
23. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.
Ohmatsu H; Humme D; Gulati N; Gonzalez J; Möbs M; Suárez-Fariñas M; Cardinale I; Mitsui H; Guttman-Yassky E; Sterry W; Krueger JG
Cancer Immunol Res; 2014 Sep; 2(9):890-900. PubMed ID: 24938282
[TBL] [Abstract][Full Text] [Related]
24. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory Vitiligo or Hypopigmented Mycosis Fungoides?
Gomez-Moyano E; Vera-Casaño A; Gamero AH; Sanz-Trelles A; Crespo-Erchiga V
J Pediatr Hematol Oncol; 2010 May; 32(4):338-9. PubMed ID: 20418787
[No Abstract] [Full Text] [Related]
26. Clinical and histopathological features of folliculotropic mycosis fungoides: a Norwegian patient series.
Mantaka P; Helsing P; Gjersvik P; Bassarova A; Clausen OP; Delabie J
Acta Derm Venereol; 2013 May; 93(3):325-9. PubMed ID: 23053197
[TBL] [Abstract][Full Text] [Related]
27. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of Fas in tumour-stage mycosis fungoides (MF) and MF-like cutaneous T-cell pseudolymphoma.
Debusscher C; Simonart T
Br J Dermatol; 2001 Apr; 144(4):903. PubMed ID: 11298560
[No Abstract] [Full Text] [Related]
29. Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis.
Cowen EW; Liu CW; Steinberg SM; Kang S; Vonderheid EC; Kwak HS; Booher S; Petricoin EF; Liotta LA; Whiteley G; Hwang ST
Br J Dermatol; 2007 Nov; 157(5):946-53. PubMed ID: 17854367
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.
Kelemen K; White CR; Gatter K; Braziel RM; Fan G
Am J Clin Pathol; 2010 Nov; 134(5):739-48. PubMed ID: 20959657
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
[TBL] [Abstract][Full Text] [Related]
32. Monocytopoiesis in chronic eczematous diseases, psoriasis vulgaris, and mycosis fungoides.
Meuret G; Schmitt E; Hagedorn M
J Invest Dermatol; 1976 Jan; 66(1):22-8. PubMed ID: 1245754
[TBL] [Abstract][Full Text] [Related]
33. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.
Dereure O; Levi E; Vonderheid EC; Kadin ME
J Invest Dermatol; 2002 Jun; 118(6):949-56. PubMed ID: 12060388
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotypic shift from CD4(+) to CD8(+) in mycosis fungoides.
Endo C; Naka Y; Miyagaki T; Fujita H; Sugaya M; Kawashima M; Tsunemi Y
Br J Dermatol; 2016 Oct; 175(4):830-3. PubMed ID: 27167533
[No Abstract] [Full Text] [Related]
35. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
Knapp CF; Mathew R; Messina JL; Lien MH
Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
[TBL] [Abstract][Full Text] [Related]
36. The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation.
Iliadis A; Koletsa T; Patsatsi A; Georgiou E; Sotiriadis D; Kostopoulos I
Eur J Dermatol; 2016 Dec; 26(6):566-571. PubMed ID: 27545221
[TBL] [Abstract][Full Text] [Related]
37. Selective immunological evaluation of mycosis fungoides.
Cooperrider PA; Roenigk HH
Arch Dermatol; 1978 Feb; 114(2):207-12. PubMed ID: 629547
[TBL] [Abstract][Full Text] [Related]
38. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern.
Quaglino P; Osella-Abate S; Novelli M; Lisa F; Comessatti A; Bernengo MG
Eur J Dermatol; 2001; 11(6):560-3. PubMed ID: 11701409
[TBL] [Abstract][Full Text] [Related]
40. Effect of serum of mycosis fungoides patients on lymphocyte transformation.
Kinoshita M; Kawada A
J Dermatol; 1976 Aug; 3(4):115-9. PubMed ID: 15633964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
